H2020Doctoral network2016–2020

OMA · Optimization of Medical Accelerators

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2016-02-01 → 2020-01-31
EU contribution
€3,852,879
Participants
24
Scheme
MSCA-ITN

Lines connect the coordinator with its partners. CORDIS does not always give exact coordinates for projects before 2014. These points are placed at city or country level.

Results in brief

Optimization of Medical Accelerators

The OMA network has been built around 15 early stage researchers (ESRs) working on dedicated projects to maximize the benefits of the use of particle beams for cancer treatment. The network consists of an international consortium of 38 partner organizations working in this field. It has provided a cross-sector interdisciplinary environment for beyond state-of-the-art research, researcher training, and new collaborations. The network has pushed technologies and simulation techniques significantly beyond the state-of-the-art and developed solutions that are now applied in clinical practice. The project has also established a comprehensive and unique postgraduate training concept that can also be applied to other research areas and that was presented to educators at national and international learning and teaching events. The Fellows have benefited from a well-rounded training and successfully completed their projects within the network.

Data: CORDIS, © European Union

Project objective

Cancer is a major social problem, and it is the main cause of death between the ages 45-65 years. In the treatment of cancer, radio therapy (RT) plays an essential role. RT with hadrons (protons and light ions), due to their unique physical and radiobiological properties, offers several advantages over photons for specific cancer types. In particular, they penetrate the patient with minimal diffusion, they deposit maximum energy at the end of their range, and they can be shaped as narrow focused and scanned pencil beams of variable penetration depth. Although significant progress has been made in the use of particle beams for cancer treatment, an extensive research and development program is still needed to maximize the healthcare benefits from these therapies. The Optimization of Medical Accelerators (OMA) is the aim of the here-proposed European Training Network, in line with the requirements of the EC’s Medical Exposure Directive. OMA joins universities, research centers and clinical facilities with industry partners to address the challenges in treatment facility design and optimization, numerical simulations for the development of advanced treatment schemes, and in beam imaging and treatment monitoring.The proposed R&D program ranges from life sciences (oncology, cell and micro biology and medical imaging.), physics and accelerator sciences, mathematics and IT, to engineering. It is hence ideally suited for an innovative training of early stage researchers. By closely linking all above research areas, OMA will provide an interdisciplinary education to its Fellows. This will equip them with solid knowledge also in research areas adjacent to their core research field, as well as with business competences and hence give them a perfect basis for a career in research.

Original text from CORDIS.

Participants

  • THE UNIVERSITY OF LIVERPOOL · LIVERPOOLCoordinatorUnited Kingdom
  • AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS · MadridSpain
  • AMSTERDAM SCIENTIFIC INSTRUMENTS BV · AmsterdamNetherlands
  • COSYLAB LABORATORIJ ZA KONTROLNE SISTEME DD · LjubljanaSlovenia
  • Clatterbridge Cancer Centre · BirkenheadUnknown Region
  • EBG MEDAUSTRON GMBH · WIENER NEUSTADTAustria
  • FONDAZIONE CENTRO NAZIONALE DI ADROTERAPIA ONCOLOGICA · PAVIA PVItaly
  • Fistral Training and Consultancy Ltd. · GlasgowUnknown Region
  • GSI HELMHOLTZZENTRUM FUR SCHWERIONENFORSCHUNG GMBH · DarmstadtGermany
  • Holdsworth Associates · CambridgeCity levelUnknown Region
  • INVENTYA LTD · WarringtonUnited Kingdom
  • ION BEAM APPLICATIONS SA · Ottignies Louvain La NeuveBelgium
  • ISTITUTO NAZIONALE DI FISICA NUCLEARE · FrascatiItaly
  • LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN · PlaneggGermany
  • ORGANISATION EUROPEENNE POUR LA RECHERCHE NUCLEAIRE · GENEVE 23Switzerland
  • PAUL SCHERRER INSTITUT · VILLIGEN PSISwitzerland
  • THE UNIVERSITY OF MANCHESTER · ManchesterUnited Kingdom
  • The Christie · ManchesterUnknown Region
  • UK Intellectual Property Office · NewportUnknown Region
  • UNITED KINGDOM RESEARCH AND INNOVATION · SWINDONUnited Kingdom
  • UNIVERSIDAD DE SEVILLA · SevillaSpain
  • UNIVERSITY COLLEGE LONDON · LondonUnited Kingdom
  • UNIVERSITY OF LANCASTER · LANCASTERUnited Kingdom
  • VIALUX MESSTECHNIK + BILDVERARBEITUNG GMBH · CHEMNITZGermany

Links

Data: CORDIS, © European Union